These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 14716308

  • 1. Therapeutic effects of lysophosphatidylcholine in experimental sepsis.
    Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HW, Kim YH, Song DK.
    Nat Med; 2004 Feb; 10(2):161-7. PubMed ID: 14716308
    [Abstract] [Full Text] [Related]

  • 2. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis.
    Ma H, Kou J, Zhu D, Yan Y, Yu B.
    Int Immunopharmacol; 2006 Aug; 6(8):1355-62. PubMed ID: 16782549
    [Abstract] [Full Text] [Related]

  • 3. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.
    Radu CG, Yang LV, Riedinger M, Au M, Witte ON.
    Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):245-50. PubMed ID: 14681556
    [Abstract] [Full Text] [Related]

  • 4. LPS pretreatment by the oral route protects against sepsis induced by cecal ligation and puncture. Regulation of proinflammatory response and IgM anti-LPS antibody production as associated mechanisms.
    Márquez-Velasco R, Massó F, Hernández-Pando R, Montaño LF, Springall R, Amezcua-Guerra LM, Bojalil R.
    Inflamm Res; 2007 Sep 06; 56(9):385-90. PubMed ID: 17879001
    [Abstract] [Full Text] [Related]

  • 5. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW, Lusis AJ, Kabarowski JH.
    Arterioscler Thromb Vasc Biol; 2006 Dec 06; 26(12):2703-9. PubMed ID: 16990555
    [Abstract] [Full Text] [Related]

  • 6. The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection.
    Kim SD, Kim YK, Lee HY, Kim YS, Jeon SG, Baek SH, Song DK, Ryu SH, Bae YS.
    J Immunol; 2010 Oct 01; 185(7):4302-10. PubMed ID: 20817875
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii.
    Smani Y, Domínguez-Herrera J, Ibáñez-Martínez J, Pachón J.
    Antimicrob Agents Chemother; 2015 Jul 01; 59(7):3920-4. PubMed ID: 25896698
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC, Gomes RN, Bozza FA, Amâncio RT, Bozza PT, David CM, Castro-Faria-Neto HC.
    Shock; 2004 Feb 01; 21(2):115-20. PubMed ID: 14752283
    [Abstract] [Full Text] [Related]

  • 9. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.
    Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K, Ulloa L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H.
    J Lipid Res; 2005 Apr 01; 46(4):623-7. PubMed ID: 15687351
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis.
    Schmidt C, Kurt B, Höcherl K, Bucher M.
    Shock; 2009 Sep 01; 32(3):239-46. PubMed ID: 19106815
    [Abstract] [Full Text] [Related]

  • 11. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality.
    Pan P, Cardinal J, Dhupar R, Rosengart MR, Lotze MT, Geller DA, Billiar TR, Tsung A.
    J Leukoc Biol; 2009 Sep 01; 86(3):625-32. PubMed ID: 19487305
    [Abstract] [Full Text] [Related]

  • 12. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats.
    Feng X, Yan W, Liu X, Duan M, Zhang X, Xu J.
    J Surg Res; 2006 Sep 01; 135(1):129-36. PubMed ID: 16616763
    [Abstract] [Full Text] [Related]

  • 13. Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism.
    Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR.
    Crit Care Med; 2006 Oct 01; 34(10):2624-9. PubMed ID: 16932233
    [Abstract] [Full Text] [Related]

  • 14. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.
    Bedirli A, Kerem M, Pasaoglu H, Akyurek N, Tezcaner T, Elbeg S, Memis L, Sakrak O.
    Shock; 2007 Apr 01; 27(4):397-401. PubMed ID: 17414422
    [Abstract] [Full Text] [Related]

  • 15. Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis.
    Hegde A, Zhang H, Moochhala SM, Bhatia M.
    J Leukoc Biol; 2007 Sep 01; 82(3):678-85. PubMed ID: 17565047
    [Abstract] [Full Text] [Related]

  • 16. Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate.
    Yamada M, Ichikawa T, Ii M, Sunamoto M, Itoh K, Tamura N, Kitazaki T.
    J Med Chem; 2005 Nov 17; 48(23):7457-67. PubMed ID: 16279805
    [Abstract] [Full Text] [Related]

  • 17. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
    Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y.
    Science; 2001 Jul 27; 293(5530):702-5. PubMed ID: 11474113
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury.
    Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H.
    Ann Surg; 2009 Nov 27; 250(5):783-90. PubMed ID: 19806052
    [Abstract] [Full Text] [Related]

  • 19. Selective macrophage suppression during sepsis.
    Ellaban E, Bolgos G, Remick D.
    Cell Immunol; 2004 Nov 27; 231(1-2):103-11. PubMed ID: 15919375
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor necrosis factor alpha F(ab')2 antibody fragments protect in murine polymicrobial sepsis: concentration and early intervention are fundamental to the outcome.
    Márquez-Velasco R, Bojalil R, Buelna A, Flores-Guzmán F, Estevez-Ramirez J, Laguna J, Hernández AM, Díaz-Quiñonez A, Paniagua-Solís JF.
    Inflamm Res; 2006 Sep 27; 55(9):378-84. PubMed ID: 17122959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.